NCT01063075 2019-09-26A Study in Advanced Solid TumorsEli Lilly and CompanyPhase 2 Completed34 enrolled 15 charts
NCT00622674 2017-12-02Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsMasonic Cancer Center, University of MinnesotaPhase 1 Completed37 enrolled